{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:35:57Z","timestamp":1761129357762},"reference-count":34,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00239","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T03:20:51Z","timestamp":1465874451000},"update-policy":"http:\/\/dx.doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Combined Expression of IFN-\u03b3, IL-17, and IL-4 mRNA by Recall PBMCs Moderately Discriminates Active Tuberculosis from Latent Mycobacterium tuberculosis Infection in Patients with Miscellaneous Inflammatory Underlying Conditions"],"prefix":"10.3389","volume":"7","author":[{"given":"Laura E.","family":"Savolainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Kantele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aija","family":"Knuuttila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana","family":"Pusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riitta","family":"Karttunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heikki","family":"Valleala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Tuuminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/1469-0691.12129","article-title":"Interferon-gamma release assays in the diagnosis of active tuberculosis disease in a low-incident setting: a 5-year review of data","volume":"19","author":"Lavender","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"B4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/annrheumdis-2013-204575","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis","volume":"73","author":"Ramiro","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.cytogfr.2010.10.004","article-title":"IL-17 and Th17 cells in tuberculosis","volume":"21","author":"Torrado","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/eji.200738120","article-title":"Role of Foxp3-positive regulatory T cells during infection","volume":"38","author":"Belkaid","year":"2008","journal-title":"Eur J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20091885","article-title":"Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis","volume":"207","author":"Shafiani","year":"2010","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1164\/rccm.200508-1294OC","article-title":"Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis","volume":"173","author":"Guyot-Revol","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.tube.2010.05.003","article-title":"Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis","volume":"90","author":"Marin","year":"2010","journal-title":"Tuberculosis (Edinb)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.it.2004.06.005","article-title":"IL-4 in tuberculosis: implications for vaccine design","volume":"25","author":"Rook","year":"2004","journal-title":"Trends Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1164\/rccm.200502-278OC","article-title":"In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis","volume":"172","author":"Dheda","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1128\/IAI.74.5.2817-2822.2006","article-title":"The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon","volume":"74","author":"Demissie","year":"2006","journal-title":"Infect Immun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.4049\/jimmunol.172.11.6938","article-title":"Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2","volume":"172","author":"Demissie","year":"2004","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1522","DOI":"10.1371\/journal.pone.0001522","article-title":"Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time","volume":"3","author":"Wassie","year":"2008","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1046\/j.1365-2249.2000.01328.x","article-title":"Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls","volume":"122","author":"Lenarczyk","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.4049\/jimmunol.178.6.3688","article-title":"Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease","volume":"178","author":"Wu","year":"2007","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2144\/04371RR03","article-title":"Validation of housekeeping genes for normalizing RNA expression in real-time PCR","volume":"37","author":"Dheda","year":"2004","journal-title":"Biotechniques"},{"key":"B20","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1086\/511277","article-title":"Immunosuppression during active tuberculosis is characterized by decreased interferon-gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels","volume":"195","author":"Roberts","year":"2007","journal-title":"J Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-3083.2011.02512.x","article-title":"ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection","volume":"73","author":"Qiao","year":"2011","journal-title":"Scand J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2249.2007.03399.x","article-title":"FOXP3 gene expression in a tuberculosis case contact study","volume":"149","author":"Burl","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e12365","DOI":"10.1371\/journal.pone.0012365","article-title":"Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort","volume":"5","author":"Sutherland","year":"2010","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1093\/rheumatology\/keq224","article-title":"Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression","volume":"49","author":"Aerts","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"B26","first-page":"18","article-title":"Serum levels of IL-17, IL-4, and INFgamma in Serbian patients with early rheumatoid arthritis","volume":"19","author":"Pavlovic","year":"2014","journal-title":"J Res Med Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1164\/rccm.200909-1463OC","article-title":"Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells","volume":"7","author":"Chen","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1128\/CVI.00390-12","article-title":"Reduced frequency of memory T cells and increased th17 responses in patients with active tuberculosis","volume":"19","author":"Mar\u00edn","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12026-011-8229-7","article-title":"Latent tuberculosis: what the host \u201csees\u201d?","volume":"50","author":"Gideon","year":"2011","journal-title":"Immunol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e24290","DOI":"10.1371\/journal.pone.0024290","article-title":"Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells","volume":"6","author":"Lu","year":"2011","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.diagmicrobio.2012.09.015","article-title":"Interferon gamma mRNA quantitative real-time polymerase chain reaction for the diagnosis of latent tuberculosis: a novel interferon gamma release assay","volume":"75","author":"Kim","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.tube.2012.12.002","article-title":"Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB","volume":"93","author":"Mar\u00edn","year":"2013","journal-title":"Tuberculosis (Edinb)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1128\/IAI.00592-09","article-title":"Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model","volume":"77","author":"Lin","year":"2009","journal-title":"Infect Immun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T18:08:18Z","timestamp":1568052498000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2016.00239\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,14]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00239","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,14]]}}}